How many institutions held TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in Q1 2025?

136 institutional investors reported TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value for Q1 2025. Use the holders table for investor-level position and value details.

TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Q: What does CUSIP 89455T109 represent in this 13F holders report?

CUSIP 89455T109 is the security identifier for TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 89455T109

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common stock, $0.001 par value
Total 13F shares: 37,892,233
Total 13F value: $314,933,438
Share change: +732,950
Put/Call ratio: 7.6%
SEC-reported price per share: $8.39
Number of holders: 136
Value change: +$6,396,329
Number of buys: 67
Number of sells: 68
Shares outstanding: 65,005,107

Security key

89455T109

Report period

Q1 2025

Institutions

136

Top holders

TMCI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 TREACE MEDICAL CONCEPTS, INC. SEC filings TREACE MEDICAL CONCEPTS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 89455T109

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

John R. Treace

Comparable rows

1/15

Latest evidence

31 Dec 2024

13F 13D/G 3/4/5 Lead comparable stake: 3.4% 14 rows are not safely comparable across share classes. 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 3.4%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 1

MORGAN STANLEY 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F 13D/G Company 13F 13D/G	3.4% Reported 13D/G · 31 Dec 2024	$15,932,506 2,141,466 shares	—	31 Dec 2024
John R. Treace	3/4/5 Director 3/4/5	— denominator unverified	$59,159,875 2,231,606 shares	—	09 May 2022
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$46,194,960 6,209,000 shares	—	31 Dec 2024
Thomas E. Timbie	3/4/5 Director 3/4/5	— denominator unverified	$40,111,326 1,513,064 shares	—	15 Mar 2023
BlackRock, Inc.	13F Company 13F	— denominator unverified	$28,079,290 3,774,098 shares	—	31 Dec 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$21,865,029 2,938,848 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

136

37,892,233

Rows available

136

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q3 2025 Across Filers

Q3 2025 holders

117

Q1 2025 holders

136

Holder diff

Investor	Q3 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q3 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend